Canada Pension Plan Investment Board
NPCE icon

Canada Pension Plan Investment Board’s Neuropace NPCE Stock Holding History

Canada Pension Plan Investment Board’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$351K Sell
22,100
-5,700
-21% -$91.7K ﹤0.01% 1398
2026
Q1 		$366K Buy
27,800
+7,600
+38% +$114K ﹤0.01% 1343
2025
Q4 		$312K Buy
+20,200
New +$270K ﹤0.01% 1500

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Canada Pension Plan Investment Board's NPCE Position: Q2 2026 in Review

Canada Pension Plan Investment Board reduced its Neuropace (NPCE) stake by 21% in Q2 2026, selling an estimated $91.7K and leaving 22,100 shares worth $351K. The position accounts for ﹤0.01% of the portfolio, ranked #1398.

Canada Pension Plan Investment Board first reported a position in NPCE in Q4 2025 and has held it in 3 quarters since. The position peaked at $366K in Q1 2026. 112 funds tracked by Wall St. Rank hold NPCE as of Q2 2026.

  • Canada Pension Plan Investment Board held 22,100 shares of Neuropace worth $351K as of Q2 2026.
  • Canada Pension Plan Investment Board sold 5,700 Neuropace shares in Q2 2026, an estimated $91.7K.
  • Neuropace made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1398 holding.
  • Canada Pension Plan Investment Board first reported a position in Neuropace in Q4 2025 and has held it in 3 quarters since.
  • Canada Pension Plan Investment Board's Neuropace position peaked at $366K in Q1 2026.
  • 112 funds tracked by Wall St. Rank held Neuropace as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.